File Download
There are no files associated with this item.
Links for fulltext
(May Require Subscription)
- Publisher Website: 10.1016/j.jdent.2022.104356
- Scopus: eid_2-s2.0-85141942609
- PMID: 36370897
- WOS: WOS:000891945700005
- Find via
Supplementary
- Citations:
- Appears in Collections:
Article: Synbiotic-fluoride synergism on enamel remineralization, cytotoxicity and genotoxicity
Title | Synbiotic-fluoride synergism on enamel remineralization, cytotoxicity and genotoxicity |
---|---|
Authors | |
Keywords | Arginine Fluoride Remineralization Synbiotic Toxicity |
Issue Date | 2023 |
Citation | Journal of Dentistry, 2023, v. 128, article no. 104356 How to Cite? |
Abstract | Objective(s): The objectives of the present study were to examine the – a) enamel remineralization potential of synbiotic-fluoride (SF) therapy using a multi-species bacterial pH-cycling model; and b) cytotoxic and genotoxic effects of SF therapy extracts. Materials and methods: The SF therapy group comprised of 2% arginine (Arg), 0.2% NaF, and a probiotic Lactobacillus rhamnosus GG (LRG). The intervention groups studied were: 1) No treatment; 2) 2% Arg; 3) 0.2% NaF; 4) LRG; 5) 2% Arg+0.2% NaF; 6) 2% Arg+LRG; 7) 0.2% NaF+LRG; and 8) 2% Arg+0.2% NaF+LRG (SF therapy). The enamel remineralization potential of SF therapy was investigated under cariogenic biofilm challenge; while the cytotoxicity and genotoxicity of SF therapy extracts were examined on HGF-1 and Chinese hamster fibroblast V79, respectively. To determine the remineralization effect, the specimens were subjected to mineral density (MD) assessment using micro-CT, Ca/P molar ratio with SEM-EDX, and enamel fluoride uptake (EFU) estimates. The HGF-1 proliferation assessment was quantified using MTT/CCK-8 assays with qualitative analysis by nuclei staining Hoechst-based fluorescence imaging. The genotoxicity was determined by micronuclei formation test. Results: Mineral gain and %remineralization derived from MD assessment for the SF therapy were significantly higher than the other groups (p<0.05). The %ΔCa/P for the SF and 2% Arg+0.2% NaF were significantly higher than the other groups (p<0.05). The SF and 2% Arg+0.2% NaF groups had the highest EFU compared to the other groups (p<0.05). No significant difference in the %viable HGF-1 cells were observed between the treatment interventions and no treatment group (p>0.05). Compared to the EMS-positive control, the micronuclei formation for all the intervention groups was significantly lower (p<0.05), with no significant difference among the treatment groups (p>0.05). Conclusion: The SF therapy enhanced enamel remineralization with no biocompatibility concerns. Clinical significance: With the enhanced enamel remineralization potential discerned in the present study, the SF therapy can be used as a promising caries-preventive agent targeted for high caries-risk individuals. |
Persistent Identifier | http://hdl.handle.net/10722/336415 |
ISSN | 2023 Impact Factor: 4.8 2023 SCImago Journal Rankings: 1.313 |
ISI Accession Number ID |
DC Field | Value | Language |
---|---|---|
dc.contributor.author | BIJLE, Mohammed Nadeem | - |
dc.contributor.author | ABDALLA, Mohamed Mahmoud | - |
dc.contributor.author | CHU, Chun Hung | - |
dc.contributor.author | YIU, Cynthia Kar Yung | - |
dc.date.accessioned | 2024-01-15T08:26:41Z | - |
dc.date.available | 2024-01-15T08:26:41Z | - |
dc.date.issued | 2023 | - |
dc.identifier.citation | Journal of Dentistry, 2023, v. 128, article no. 104356 | - |
dc.identifier.issn | 0300-5712 | - |
dc.identifier.uri | http://hdl.handle.net/10722/336415 | - |
dc.description.abstract | Objective(s): The objectives of the present study were to examine the – a) enamel remineralization potential of synbiotic-fluoride (SF) therapy using a multi-species bacterial pH-cycling model; and b) cytotoxic and genotoxic effects of SF therapy extracts. Materials and methods: The SF therapy group comprised of 2% arginine (Arg), 0.2% NaF, and a probiotic Lactobacillus rhamnosus GG (LRG). The intervention groups studied were: 1) No treatment; 2) 2% Arg; 3) 0.2% NaF; 4) LRG; 5) 2% Arg+0.2% NaF; 6) 2% Arg+LRG; 7) 0.2% NaF+LRG; and 8) 2% Arg+0.2% NaF+LRG (SF therapy). The enamel remineralization potential of SF therapy was investigated under cariogenic biofilm challenge; while the cytotoxicity and genotoxicity of SF therapy extracts were examined on HGF-1 and Chinese hamster fibroblast V79, respectively. To determine the remineralization effect, the specimens were subjected to mineral density (MD) assessment using micro-CT, Ca/P molar ratio with SEM-EDX, and enamel fluoride uptake (EFU) estimates. The HGF-1 proliferation assessment was quantified using MTT/CCK-8 assays with qualitative analysis by nuclei staining Hoechst-based fluorescence imaging. The genotoxicity was determined by micronuclei formation test. Results: Mineral gain and %remineralization derived from MD assessment for the SF therapy were significantly higher than the other groups (p<0.05). The %ΔCa/P for the SF and 2% Arg+0.2% NaF were significantly higher than the other groups (p<0.05). The SF and 2% Arg+0.2% NaF groups had the highest EFU compared to the other groups (p<0.05). No significant difference in the %viable HGF-1 cells were observed between the treatment interventions and no treatment group (p>0.05). Compared to the EMS-positive control, the micronuclei formation for all the intervention groups was significantly lower (p<0.05), with no significant difference among the treatment groups (p>0.05). Conclusion: The SF therapy enhanced enamel remineralization with no biocompatibility concerns. Clinical significance: With the enhanced enamel remineralization potential discerned in the present study, the SF therapy can be used as a promising caries-preventive agent targeted for high caries-risk individuals. | - |
dc.language | eng | - |
dc.relation.ispartof | Journal of Dentistry | - |
dc.subject | Arginine | - |
dc.subject | Fluoride | - |
dc.subject | Remineralization | - |
dc.subject | Synbiotic | - |
dc.subject | Toxicity | - |
dc.title | Synbiotic-fluoride synergism on enamel remineralization, cytotoxicity and genotoxicity | - |
dc.type | Article | - |
dc.description.nature | link_to_subscribed_fulltext | - |
dc.identifier.doi | 10.1016/j.jdent.2022.104356 | - |
dc.identifier.pmid | 36370897 | - |
dc.identifier.scopus | eid_2-s2.0-85141942609 | - |
dc.identifier.volume | 128 | - |
dc.identifier.spage | article no. 104356 | - |
dc.identifier.epage | article no. 104356 | - |
dc.identifier.isi | WOS:000891945700005 | - |